Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.
Open | $82.330 |
Close | - |
Volume / Avg. | 72.229K / 1.507M |
Day Range | 81.590 - 82.620 |
52 Wk Range | 76.020 - 99.560 |
Market Cap | $15.600B |
P/E Ratio | 77.519 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 1.63% |
Days to Cover | 2.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biomarin Pharmaceutical (NASDAQ: BMRN) through any online brokerage.
Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Biomarin Pharmaceutical (NASDAQ: BMRN) was reported by Canaccord Genuity on Friday, April 26, 2024. The analyst firm set a price target for 89.00 expecting BMRN to rise to within 12 months (a possible 8.27% upside). 48 analyst firms have reported ratings in the last year.
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $82.2 last updated Today at April 26, 2024 at 9:47 AM EDT.
There are no upcoming dividends for Biomarin Pharmaceutical.
Biomarin Pharmaceutical’s Q1 earnings are confirmed for Wednesday, April 24, 2024.
There is no upcoming split for Biomarin Pharmaceutical.
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.